论文部分内容阅读
目的:评估重庆地区调脂药的应用情况及趋势。方法:对重庆地区28家医院2004～2007年调脂药的销售金额、用药频度、日均费用等进行统计、分析。结果:该地区调脂药销售金额年增长率达33.80%以上。辛伐他汀销售金额和用药频度4年来一直位居前列,阿托伐他汀钙销售金额逐年快速增长,吉非贝齐逐年降低,年均递减60%。结论:他汀类药占重庆地区调脂药市场的主导地位,市场前景广阔。
Objective: To evaluate the application and trend of lipid-lowering drugs in Chongqing. Methods: The sales amount, medication frequency and daily average cost of lipid-lowering drugs in 28 hospitals in Chongqing from 2004 to 2007 were analyzed statistically. Results: The annual sales growth rate of lipid-lowering drugs in the region reached 33.80% or more. Simvastatin sales volume and frequency of medication has been in the forefront of 4 years, atorvastatin calcium sales increased rapidly year by year, gemfibrozil decreased year by year, an average annual decrease of 60%. Conclusion: Statins occupy the leading position in the market of lipid-lowering drugs in Chongqing with broad market prospects.